Kennedy Capital Management’s Sionna Therapeutics SION Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-12,621
Closed -$555K – 608
2026
Q2
$555K Buy
12,621
+337
+3% +$13.5K 0.01% 519
2026
Q1
$492K Buy
12,284
+5,532
+82% +$211K 0.01% 515
2025
Q4
$278K Buy
+6,752
New +$256K 0.01% 520

Other funds holding SION

Kennedy Capital Management's SION Position: Q3 2026 in Review

Kennedy Capital Management sold out of Sionna Therapeutics (SION) in Q3 2026, closing a stake of 12,621 shares — an estimated $555K sold.

Kennedy Capital Management first reported a position in SION in Q4 2025 and held it in 3 quarters. The position peaked at $555K in Q2 2026. 136 funds tracked by Wall St. Rank hold SION as of Q3 2026.

  • Kennedy Capital Management reported no remaining Sionna Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Kennedy Capital Management sold 12,621 Sionna Therapeutics shares in Q3 2026, an estimated $555K.
  • Kennedy Capital Management first reported a position in Sionna Therapeutics in Q4 2025 and held it in 3 quarters.
  • Kennedy Capital Management's Sionna Therapeutics position peaked at $555K in Q2 2026.
  • 136 funds tracked by Wall St. Rank held Sionna Therapeutics as of Q3 2026.

Based on Kennedy Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.